Compounds > methylene blue
Page last updated: 2024-08-17

methylene blue and Vascular Diseases

methylene blue has been researched along with Vascular Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clarke, AE; Del Duca, D; Ergina, PL; Lachapelle, KJ; Sheth, SS1
Fischer, S; Hagl, C; Haverich, A; Knobloch, K; Kofidis, T; Leyh, RG; Simon, AR; Strüber, M; Wachsmann, B1
Evora, PR; Levin, RL1
de Andrade, JC; Evora, PR; Ribeiro, PJ1
Anssar, M; Harringer, W; Haverich, A; Kofidis, T; Simon, A; Strüber, M; Wilhelmi, M1
Khodadoust, AA; Silverstein, AM1

Other Studies

6 other study(ies) available for methylene blue and Vascular Diseases

ArticleYear
Use of methylene blue for catecholamine-refractory vasoplegia from protamine and aprotinin.
    The Annals of thoracic surgery, 2009, Volume: 87, Issue:2

    Topics: Aged; Anaphylaxis; Aprotinin; Cardiopulmonary Bypass; Catecholamines; Coronary Artery Bypass; Drug Resistance; Female; Follow-Up Studies; Humans; Hypotension; Infusions, Intravenous; Intraoperative Complications; Male; Methylene Blue; Protamines; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vascular Diseases; Vasodilation

2009
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?
    The Journal of thoracic and cardiovascular surgery, 2003, Volume: 125, Issue:6

    Topics: Cardiopulmonary Bypass; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Male; Methylene Blue; Middle Aged; Norepinephrine; Postoperative Complications; Vascular Diseases; Vascular Resistance

2003
Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.
    The Journal of thoracic and cardiovascular surgery, 2004, Volume: 127, Issue:3

    Topics: Animals; Cardiopulmonary Bypass; Catecholamines; Enzyme Inhibitors; Guanylate Cyclase; Humans; Methylene Blue; Vascular Diseases; Vascular Resistance

2004
Methylene blue administration in SIRS after cardiac operations.
    The Annals of thoracic surgery, 1997, Volume: 63, Issue:4

    Topics: Cardiac Surgical Procedures; Humans; Inflammation; Methylene Blue; Nitric Oxide Synthase; Syndrome; Vascular Diseases; Vascular Resistance; Vasodilation

1997
Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation.
    The Journal of thoracic and cardiovascular surgery, 2001, Volume: 122, Issue:4

    Topics: Enzyme Inhibitors; Heart Transplantation; Humans; Male; Methylene Blue; Middle Aged; Remission Induction; Vascular Diseases; Vascular Resistance

2001
The survival and rejection of epithelium in experimental corneal transplants.
    Investigative ophthalmology, 1969, Volume: 8, Issue:2

    Topics: Animals; Autoradiography; Cornea; Corneal Transplantation; Epithelial Cells; Epithelium; Methylene Blue; Rabbits; Staining and Labeling; Thymidine; Transplantation Immunology; Transplantation, Homologous; Tritium; Vascular Diseases

1969